REG - IP Group PLC - Director/PDMR Shareholding

IPAnnouncement

27/10/2021 17:45

RNS Number : 4900Q
  
IP Group PLC
  
27 October 2021
  
 





FOR RELEASE ON


27 October 2021




 
IP Group plc - SAYE Option Exercise
 
IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), the developer of intellectual property-based businesses, announces the following in connection with its employee share schemes.
 
Dr Mark Reilly, Managing Partner Technology, exercised options under the Group's 2018 Save As You Earn plan ("SAYE") to buy 10,898 Shares at 99.10 pence per share. Following satisfaction of the options, Dr Reilly's beneficial interest in the Company will be 73,351 ordinary shares, representing <0.01% of the total issued share capital.
 
Shares in issue
At the date of this announcement, the Company continues to have 1,063,033,287 ordinary shares in issue (including treasury shares).
 
The following notifications, made in accordance with the requirements of article 19.3 of the EU Market Abuse Regulation, provide further details:
 
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
 




1


Details of the person discharging managerial responsibilities/person closely associated




a)


Name


Mark Reilly




2


Reason for the notification




a)


Position/status


PDMR Managing Partner, Technology
 




 


Initial notification /Amendment


Initial Notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name 


IP Group plc




b)


Legal Entity Identifier


213800HG22UM138WFG43




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a) 


Description of the financial instrument, type of instrument
Identification code


Ordinary Shares of 2p each in IP Group plc
 

ISIN: GB00B128J450




b) 


Nature of the transaction


Exercise of an option to acquire Ordinary Shares under the Group's 2018 SAYE.




c)


Currency 


GBP




d) 


Price(s) and volume(s)






Name(s)


Price(s)


Volume(s)




Mark Reilly


£0.991


 10,898 




 




e)


Aggregated information
-Aggregated volume
- Price
- Aggregated total


 
10,898
£0.991
£10,799.91




f)


Date of the transaction


13 October 2021




g)


Place of the transaction


London




 
 
For more information, please contact:
 




IP Group plc


www.ipgroupplc.com




Angela Leach, Company Secretary

Liz Vaughan-Adams, Communications            


+44 (0) 20 7444 0050

+44 (0) 20 7444 0062/+44 (0) 7979 853802




Charlotte Street Partners


 




Andrew Wilson


+44 (0) 7810 636995




David Gaffney


+44 (0) 7854 609998




 
Notes for editors
 
About IP Group
 
IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
 
For more information, please visit our website at www.ipgroupplc.com.
 
ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHPPGGCUUPGGQM